CalciMedica Inc (CALC)

Currency in USD
5.280
-0.190(-3.47%)
Closed·
5.2800.000(0.00%)
·
CALC is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
5.0505.705
52 wk Range
1.4207.200
Key Statistics
Prev. Close
5.47
Open
5.49
Day's Range
5.05-5.705
52 wk Range
1.42-7.2
Volume
80.75K
Average Volume (3m)
82.58K
1-Year Change
66.5615%
Book Value / Share
-0.02
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
CALC Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
16.250
Upside
+207.77%
Members' Sentiments
Bearish
Bullish
ProTips
Stock has taken a big hit over the last week

CalciMedica Inc News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Strong Sell

CalciMedica Inc Company Profile

CalciMedica, Inc., a clinical-stage biopharmaceutical company, focuses on developing therapeutics for illnesses caused by inflammatory and immunologic processes and direct cellular damage. The company’s lead product candidate comprises Auxora, an intravenous formulated small molecule calcium release-activated calcium (CRAC) channel inhibitors for the treatment of acute pancreatitis, asparaginase-induced pancreatic toxicity, and acute kidney injury, as well as severe COVID-19 pneumonia. It also develops Auxora for the treatment of acute ulcerative colitis, traumatic brain injury, and allergic asthma; and oral CRAC channel inhibitors for use in chronic inflammatory indications. The company is based in La Jolla, California.

Compare CALC to Peers and Sector

Metrics to compare
CALC
Peers
Sector
Relationship
P/E Ratio
−3.3x−1.3x−0.6x
PEG Ratio
0.28−0.020.00
Price/Book
−283.9x1.4x2.6x
Price / LTM Sales
-7.6x3.4x
Upside (Analyst Target)
183.4%480.3%41.3%
Fair Value Upside
Unlock10.5%4.9%Unlock

Analyst Ratings

4 Buy
0 Hold
0 Sell
Ratings:
4 analysts
Overall Consensus
Strong Buy

Analysts 12-Month Price Target:

Average 16.250
(+207.77% Upside)
Firm
ArticlePositionPrice TargetUpside / DownsideFrom Price TargetActionDate
Oppenheimer
Buy20.00+278.79%-MaintainDec 02, 2025
H.C. Wainwright
Buy16.00+203.03%-MaintainApr 01, 2025

Earnings

Latest Release
Nov 12, 2025
EPS / Forecast
-0.52 / -1.73
Revenue / Forecast
-- / --
EPS Revisions
Last 90 days

CALC Income Statement

People Also Watch

39.37
PACS
-0.30%
3.770
CLYM
-4.80%
243.79
CIEN
+2.27%
24.17
ALMS
-0.70%

FAQ

What Is the CalciMedica (CALC) Premarket Price Today?

The CalciMedica (CALC) premarket price is 5.450. Premarket price change units: -0.020. Premarket percentage change: -0.370%. Premarket volume: 1.000. Current date: 16 Jan 2026. Previous close: 5.470

What Stock Exchange Does CalciMedica Trade On?

CalciMedica is listed and trades on the Nasdaq Stock Exchange stock exchange.

What Is the Stock Symbol for CalciMedica?

The stock symbol for CalciMedica is "CALC."

What Is the CalciMedica Market Cap?

As of today, CalciMedica market cap is 76.08M.

What Is CalciMedica's Earnings Per Share (TTM)?

The CalciMedica EPS (TTM) is -1.61.

From a Technical Analysis Perspective, Is CALC a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Sell.

How Many Times Has CalciMedica Stock Split?

CalciMedica has split 1 times.

How Many Employees Does CalciMedica Have?

CalciMedica has 15 employees.

What is the current trading status of CalciMedica (CALC)?

As of 16 Jan 2026, CalciMedica (CALC) is trading at a price of 5.280, with a previous close of 5.470. The stock has fluctuated within a day range of 5.050 to 5.705, while its 52-week range spans from 1.420 to 7.200.

What Is CalciMedica (CALC) Price Target According to Analysts?

The average 12-month price target for CalciMedica is USD16.25, with a high estimate of USD20 and a low estimate of USD14. 4 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Strong Buy. The stock has an +207.77% Upside potential.

What Is the CALC Premarket Price?

CALC's last pre-market stock price is 5.450. The pre-market share volume is 1.000, and the stock has decreased by -0.020, or -0.370%.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2026 - Fusion Media Limited. All Rights Reserved.